Verition Fund Management
CGON icon

Verition Fund Management’s CG Oncology CGON Stock Holding History

Verition Fund Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,900
Closed -$992K – 2474
2025
Q4 		$992K Buy
23,900
+18,413
+336% +$762K ﹤0.01% 2164
2025
Q3 		$221K Buy
+5,487
New +$160K ﹤0.01% 3442
2025
Q2 		– Sell
-44,051
Closed -$1.08M – 3657
2025
Q1 		$1.08M Buy
+44,051
New +$1.24M 0.01% 2069
2024
Q3 		– Sell
-15,775
Closed -$498K – 3218
2024
Q2 		$498K Buy
+15,775
New +$547K ﹤0.01% 2053

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Verition Fund Management's CGON Position: Q1 2026 in Review

Verition Fund Management sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 23,900 shares — an estimated $992K sold.

Verition Fund Management first reported a position in CGON in Q2 2024 and held it in 4 quarters. The position peaked at $1.08M in Q1 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Verition Fund Management reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 23,900 CG Oncology shares in Q1 2026, an estimated $992K.
  • Verition Fund Management first reported a position in CG Oncology in Q2 2024 and held it in 4 quarters.
  • Verition Fund Management's CG Oncology position peaked at $1.08M in Q1 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.